Back to Search
Start Over
Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL)
- Source :
- RMD Open, Vol 6, Iss 3 (2020), RMD Open
- Publication Year :
- 2020
- Publisher :
- BMJ, 2020.
-
Abstract
- AimA decrease in proteinuria has been considered protective from renal damage in lupus nephritis (LN), but a cut-off point has yet to be established. The aim of this study was to identify the predictors of renal damage in patients with LN and to determine the best cut-off point for a decrease in proteinuria.MethodsWe included patients with LN defined clinically or histologically. Possible predictors of renal damage at the time of LN diagnosis were examined: proteinuria, low complement, anti-double-stranded DNA antibodies, red cell casts, creatinine level, hypertension, renal activity (assessed by the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI)), prednisone dose, immunosuppressive drugs and antimalarial use. Sociodemographic variables were included at baseline. Proteinuria was assessed at baseline and at 12 months, to determine if early response (proteinuria ResultsFive hundred and two patients with systemic lupus erythematosus patients were included; 120 patients (23.9%) accrued renal damage during their follow-up. Early response to treatment (HR=0.58), antimalarial use (HR=0.54) and a high SES (HR=0.25) were protective of renal damage occurrence, whereas male gender (HR=1.83), hypertension (HR=1.86) and the renal component of the SLEDAI (HR=2.02) were risk factors for its occurrence.ConclusionsEarly response, antimalarial use and high SES were protective of renal damage, while male gender, hypertension and higher renal activity were risk factors for its occurrence in patients with LN.
- Subjects :
- Male
medicine.medical_specialty
Immunology
Lupus nephritis
Lupus
lcsh:Medicine
urologic and male genital diseases
Gastroenterology
Autoimmune Diseases
Cohort Studies
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Rheumatology
Prednisone
Internal medicine
medicine
Humans
Lupus Erythematosus, Systemic
Immunology and Allergy
030212 general & internal medicine
030203 arthritis & rheumatology
Creatinine
Systemic lupus erythematosus
Proteinuria
Lupus erythematosus
Lupus Erythematosus
Red Cell
business.industry
Systemic
lcsh:R
medicine.disease
Lupus Nephritis
Latin America
chemistry
Cohort
medicine.symptom
business
medicine.drug
Subjects
Details
- ISSN :
- 20565933
- Volume :
- 6
- Database :
- OpenAIRE
- Journal :
- RMD Open
- Accession number :
- edsair.doi.dedup.....03973a4baffdcf2953d5df80edff3bdf
- Full Text :
- https://doi.org/10.1136/rmdopen-2020-001299